Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Labeling errors & mix-ups

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose.

1,411 FDA drug recalls with this cause, newest first.

This is exactly what it sounds like: the wrong label on the right product, the wrong strength printed on the bottle, a missing or illegible lot number and expiry date, or two products mixed up during packaging. It is dangerous precisely because the pill or liquid itself may be fine, yet the patient has no way of knowing what they are actually taking. A high share of the Class I recalls in this group are mix-ups where a stronger product ended up in a weaker product's packaging.

Class III · Low risk

PreviDent 5000 ppm

Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.

Terminated Labeling / mix-up Colgate Palmolive Co NDC 0126-0016-61 D-0521-2017
Class III · Low risk

Q Care Continue Care Kit for the non-ventilated patient

Labeling: Incorrect or Missing Lot and/or Exp Date: The expiration date of the Q Care Continue Care kit is printed with an expiration date of November 13, 2017; rather than the correct date of August 28, 2017 (date of expiration of the Corinz Antiseptic Cleansing & Moisturizing Oral Rinse). Note, the correct expiration date of August 28, 2017, is printed on the Corinz Oral Rinse package.

Terminated Labeling / mix-up Sage Products Inc D-0489-2017
Class II · Moderate risk

Transderm Scop

Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.

Terminated Labeling / mix-up Sandoz Inc NDC 66758-208-58 D-0481-2017
Class III · Low risk

Buffered Lidocaine

Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%

Terminated Labeling / mix-up Pharmedium Services, LLC D-0603-2017
Class III · Low risk

Amoxicillin for Oral suspension

Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.

Terminated Labeling / mix-up West-Ward Pharmaceuticals Corp. NDC 0143-9887-01 D-0147-2017
Class III · Low risk

Invokamet (canagliflozin and metformin HCl)

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

Terminated Labeling / mix-up Janssen Ortho L.L.C. NDC 50458-543-60 D-0115-2017
Class III · Low risk

Zeasorb AF

Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".

Terminated Labeling / mix-up GSK Consumer Healthcare NDC 0145-1506-01 D-0142-2017
Class III · Low risk

Xanax (Alprazolam)

Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry).

Terminated Labeling / mix-up Mckesson Packaging Services NDC 63739-669-10 D-1527-2016
Class III · Low risk

Lansoprazole Delayed-Release Capsules

Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules.

Terminated Labeling / mix-up Mckesson Packaging Services NDC 63739-0555-10 D-1550-2016
Class III · Low risk

Ramipril Capsules

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

Ongoing Labeling / mix-up Actavis Laboratories, FL, Inc. NDC 16252-570-30 D-0118-2017